Indiana University-Purdue University Indianapolis (IUPUI) / Formocresol is the most commonly used pharmacologic pulpotomy agent.
Concerns over its safety have led investigators to search for new pulpotomy
medicaments. This study compared the electrosurgical pulpotomy with the
formocresol pulpotomy in teeth requiring pulp therapy after carious
involvement. There were 25 pulpotomies performed in each group. The teeth
were evaluated for clinical and radiographic success after at least six months. In
the electrosurgical group, the clinical and radiographic success rates were 96
percent and 84 percent, respectively. The age range at the time of treatment was
26 to 97 months, with a mean treatment age of 63.6 months. The postoperative
observation time range was six to 31 months, with the mean being 10.9 months.
In the formocresol group, the clinical and radiographic success rates were 100
percent and 92 percent, respectively. The age range at the time of treatment was
32 to 126 months, with a mean treatment age of 68.2 months. The postoperative
observation time ranged from five to 25 months, with the mean being 11.5
months. The electrosurgical and forrnocresol groups were compared for
differences in the percentage of successes by using a Fisher's Exact test. There
were no statistical differences between the two groups at the p < 0.05 level.
Therefore, this study failed to demonstrate a statistically significant difference in
the success rate between the electrosurgical and formocresol pulpotomy
techniques and supports the use of the electrosurgical pulpotomy as a viable and
safe alternative to formocresol.
Identifer | oai:union.ndltd.org:IUPUI/oai:scholarworks.iupui.edu:1805/4133 |
Date | January 1997 |
Creators | Fulkerson, Bradley Todd |
Contributors | Dean, Jeffrey A., Sanders, Brian J., Zunt, Susan L., 1951-, Legan, Joseph E., Avery, David R. |
Source Sets | Indiana University-Purdue University Indianapolis |
Language | en_US |
Detected Language | English |
Type | Thesis |
Page generated in 0.0024 seconds